268 related articles for article (PubMed ID: 25005189)
1. Physiopathological roles of P2X receptors in the central nervous system.
Burnstock G
Curr Med Chem; 2015; 22(7):819-44. PubMed ID: 25005189
[TBL] [Abstract][Full Text] [Related]
2. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signalling: past, present and future.
Burnstock G
Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
[TBL] [Abstract][Full Text] [Related]
4. Purinergic Signalling and Neurological Diseases: An Update.
Burnstock G
CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
[TBL] [Abstract][Full Text] [Related]
5. Nociceptive transmission and modulation via P2X receptors in central pain syndrome.
Kuan YH; Shyu BC
Mol Brain; 2016 May; 9(1):58. PubMed ID: 27230068
[TBL] [Abstract][Full Text] [Related]
6. A Central Role for ATP Signalling in Glial Interactions in the CNS.
Rivera A; Vanzulli I; Butt AM
Curr Drug Targets; 2016; 17(16):1829-1833. PubMed ID: 27400972
[TBL] [Abstract][Full Text] [Related]
7. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
Apolloni S; Montilli C; Finocchi P; Amadio S
FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
[TBL] [Abstract][Full Text] [Related]
8. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
9. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
10. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
11. P2X receptors and their roles in astroglia in the central and peripheral nervous system.
Illes P; Verkhratsky A; Burnstock G; Franke H
Neuroscientist; 2012 Oct; 18(5):422-38. PubMed ID: 22013151
[TBL] [Abstract][Full Text] [Related]
12. Introduction to Purinergic Signalling in the Brain.
Burnstock G
Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706
[TBL] [Abstract][Full Text] [Related]
13. Contribution of P2X4 Receptors to CNS Function and Pathophysiology.
Montilla A; Mata GP; Matute C; Domercq M
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756482
[TBL] [Abstract][Full Text] [Related]
14. Introduction to purinergic signalling in the brain.
Burnstock G
Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061
[TBL] [Abstract][Full Text] [Related]
15. Purinergic Signalling: Therapeutic Developments.
Burnstock G
Front Pharmacol; 2017; 8():661. PubMed ID: 28993732
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signalling and disorders of the central nervous system.
Burnstock G
Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979
[TBL] [Abstract][Full Text] [Related]
17. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
18. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases.
Illes P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825423
[TBL] [Abstract][Full Text] [Related]
19. P2X and P2Y receptors—role in the pathophysiology of the nervous system.
Puchałowicz K; Tarnowski M; Baranowska-Bosiacka I; Chlubek D; Dziedziejko V
Int J Mol Sci; 2014 Dec; 15(12):23672-704. PubMed ID: 25530618
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
